Chasing Breakthrough Innovation in a Time of Uncertainty With Insights from McKinsey & Company

News provided by

Sep 19, 2023, 14:00 ET

Friday, October 6, 2023 • 7:30 a.m.-4:00 p.m. Bridgewater Marriott, 700 Commons Way, Bridgewater

TRENTON, N.J., Sept. 19, 2023 /PRNewswire/ -- BioNJ has released the agenda and speaker roster for its Eleventh Annual C-Suite Summit, taking place Friday, October 6, 2023, at the Bridgewater Marriott. The C-Suite Summit brings together life sciences executives representing a wide breadth of companies from early to late stage, public and private and revenue and pre-revenue to discuss the topics impacting C-Suite decision-making in bringing new innovative treatments to market.

"As the policy environment churns and investment in biopharma fluctuates, questions are being raised about the future of innovation for our industry," said BioNJ President and CEO, Debbie Hart. "The C-Suite Summit allows stakeholders to come together for an open conversation on where the greatest opportunities lie and how to best prepare for and shape the next paradigm in life sciences and medical discovery."

The speaker roster, featuring world-class leaders, includes:

Ronald Bartek, Co-Founder, Founding President, Friedreich's Ataxia Research Alliance (FARA)
Julie Bensignor, Senior Vice President, Human Resources, Research & Development, Bristol Myers Squibb
Ariel Berger, Executive Director, Integrated Solutions, Real-World Evidence, Evidera/PPD
Siddhartha Bhattacharya, Partner, Technology Consulting Partner, PWC
Giovanni Caforio, M.D., Chair & CEO, Bristol Myers Squibb
Tom Cavanaugh, Company Group Chairman, Global Commercial Strategy Organization, The Janssen Pharmaceutical Companies of Johnson & Johnson
Ambrose Delpino, PharmD, Head, Market Access Strategy, Oncology, Novartis
Amadou Diarra, Ph.D., Senior Vice President, Global Policy, Advocacy & Government Affairs, Bristol Myers Squibb & Chair, BioNJ
Deborah Glasser, Head of Vaccines, NA, Sanofi
Angus Grant, Ph.D., Executive Vice President, Business Development, Teva Pharmaceuticals
Debbie Hart, President & CEO, BioNJ
Samit Hirawat, M.D., Executive Vice President & Chief Medical Officer, Bristol Myers Squibb
Mandeep Kaur, M.D., Senior Vice President, Global Medical Affairs and Health Outcomes Research, Horizon Therapeutics
Olivier Leclerc, Senior Partner, McKinsey & Company
Adam Lohr, Partner, Life Sciences Senior Analyst, RSM
Michael Margolis, Senior Managing Director, Co-Head, Healthcare Investment Banking, Oppenheimer
Lynn Martin, President, NYSE Group
Jyoti Mehra, Executive Vice President, Human Resources, Gilead
Greg Meyers, Executive Vice President & Chief Digital & Technology Officer, Bristol Myers Squibb
Mark Michelet, Strategic Client Technology Director, Microsoft
Christine Ann Miller, President & CEO, Melinta Therapeutics
Kathy Oates, CHRO US Commercial, GSK
Anthony Pagano, Chief Financial Officer, Genmab
Mark Pellegrino, Senior Vice President & Chief Information Officer, Insmed
Emilio Ragosa, Managing Partner, DLA Piper
Martin Rexroad, Chief Culture & Community Officer, PTC Therapeutics
Barbara Ryan, Board Member, Indivior PLC & Senior Advisor, EY
Nisha Subramanian, Partner, McKinsey & Company
Eric Tokat, Co-President & Partner, Centerview Partners
Arda Ural, Ph.D., Americas Industry Market Leader – Life Sciences & Healthcare, Ernst & Young

Topics to be discussed:

State of the Industry
Creating Breakthroughs
Evolving Capital Markets
Navigating the Complex Path Ahead for Life Sciences Financing and M&A
The Next Horizon of Therapeutic Innovation and Patient and Industry Impact
Talent Management in Biopharma
The Transformative Impact of Digital / AI in Biopharma
Plus, an intimate Fireside Chat with Giovanni Caforio, M.D., Chair & CEO, Bristol Myers Squibb, on "The Pace of Innovation"

Click here for the full agenda.

"From access, regulation and policy to drug pricing and the implications of new technology, our experts will dive into what the industry should be doing ― and how we can work together ― to foster medical innovation and ensure Patient access," added Hart. "We hope all stakeholders will join us for this very important discussion."

Click here to register. Registration is $695 for BioNJ Members and $895 for future BioNJ Members. The C-Suite Summit is closed to media. Sponsorship opportunities are still available. Contact Cheri Hennessy at [email protected] to learn about Sponsorship opportunities.

Thank you to our Sponsors, including ADP, Amicus Therapeutics, Bristol Myer Squibb, Cohn Reznick, Crowley Law LLC, DLA Piper, Earnst & Young, Faegre Drinker, Fisher Scientific, Genmab, Herspiegel Consulting, Insmed, Marcum, McKinsey & Company, Mercer & Marsh, Merck & Co., PricewaterhouseCoopers, RSM and Sanofi.

Contact
Randi Bromberg
Sr. Vice President, Communications and Marketing
O) 609-890-3185
C) 609-955-1067
[email protected]

SOURCE BioNJ